Early complications and risk factors following reverse versus anatomic total shoulder arthroplasty for osteoarthritis: a nationwide registry study

Article information

Clin Shoulder Elb. 2025;28(2):146-155
Publication date (electronic) : 2025 April 25
doi : https://doi.org/10.5397/cise.2024.00906
1Virginia Commonwealth University School of Medicine, Richmond, VA, USA
2Department of Orthopaedic Surgery, Virginia Commonwealth University Health System, Richmond, VA, USA
Corresponding Author: Suhas Rao Velichala Virginia Commonwealth University School of Medicine, 1201 E Marshall St #4-100, Richmond, VA 23298, USA Tel: +1-626-340-5517 1 3Email: velichalasr@vcu.edu
Received 2024 November 5; Revised 2025 January 8; Accepted 2025 January 24.

Abstract

Background

Reverse shoulder arthroplasty (RSA) is an alternative to anatomic total shoulder arthroplasty (TSA) for treating glenohumeral osteoarthritis (OA), particularly in elderly patients. This study evaluates 90-day postoperative complication rates and identifies risk factors for adverse outcomes in RSA and TSA patients.

Methods

A retrospective cohort study was conducted using the TriNetX Research NLP Network to identify patients aged 65–90 years who underwent RSA or TSA for OA from 2006 to 2024. 1:1 propensity score matching controlled for demographics and comorbidities. Orthopedic and infectious complications were compared using multivariate logistic regression.

Results

The final matched cohort included 4,117 RSA and TSA patients. RSA was associated with significantly higher odds of orthopedic complications compared to TSA. Significant risk factors for orthopedic complications in RSA included nicotine dependence (odds ratio [OR], 1.592; P=0.001) and hypertension (OR, 1.545; P=0.001). In TSA, risk factors included male sex (OR, 0.702; P=0.005), chronic obstructive pulmonary disease (OR, 1.650; P=0.016), and obesity (OR, 1.776; P<0.001). For infections, RSA risk factors were male sex (OR, 1.698; P=0.005), heart failure (OR, 2.396; P<0.001), and diabetes (OR, 1.525; P=0.039). Diabetes was the only significant risk factor in TSA (OR, 2.453; P=0.003).

Conclusions

RSA carries a higher risk of orthopedic complications and infection than TSA within 90 days. Distinct risk factors for each procedure highlight the need for patient-specific risk stratification to optimize preoperative assessment and surgical decision-making.

Level of evidence

III.

INTRODUCTION

Anatomic total shoulder arthroplasty (TSA) has been the standard of care for the surgical treatment of end-stage glenohumeral osteoarthritis (OA), a condition estimated to affect 16.1%–20.1% of individuals older than 65 years [1-3]. Reverse shoulder arthroplasty (RSA) is an alternative to TSA that has gained popularity in recent years for the treatment of glenohumeral OA, largely due to a lower dependency on rotator cuff condition and the potential for faster rehabilitation of functions such as forward elevation strength [1,4-8]. As glenohumeral OA becomes more prevalent in an aging population, it is important to understand the potential complications associated with each shoulder arthroplasty approach and corresponding risk factors observed in the elderly population [9]. Prior studies have described higher all-cause postoperative complication rate for RSA compared to anatomic TSA with infection, dislocation, and revision surgery occurring at a significantly higher rate following RSA when compared to TSA [10,11]. However, recent investigations have provided evidence of the contrary, with one meta-analysis describing an advantage of RSA with respect to the rate of reoperation, complications, and several functional outcomes for patients receiving treatment for OA with an intact cuff [12]. More research is needed to establish a consensus regarding the risk profile for RSA versus TSA when applied to more recently emerged indications such as OA.

Much of the existing literature assessed the outcomes of shoulder arthroplasty performed for a broad range of indications, while little research has compared outcomes of RSA and TSA performed electively for OA specifically [13]. The present study aims to more comprehensively compare the rate of orthopedic complications in the 90-day period following TSA versus RSA among patients with OA affecting the shoulder, and to investigate risk factors for these complications. Whereas previous studies compared outcomes for RSA versus TSA, to the best of our knowledge, none have performed a highly powered database study examining such a broad array of surgical complications and their associated risk factors. We hypothesized that RSA carries a significantly higher risk of orthopedic and infectious complications compared with TSA in the 90-day postoperative period for elderly patients with glenohumeral OA, with certain comorbidities such as diabetes, hypertension, depression, and liver disease further exacerbating these risks.

METHODS

TriNetX Database

This retrospective cohort study used de-identified electronic health record (EHR) data from the TriNetX Research Network, which aggregates data from 92 healthcare organizations (HCOs), including hospitals, primary care, and specialty providers across diverse patient populations. The study specifically queried TriNetX’s Natural Language Processing dataset, which includes both insured and uninsured patients.

TriNetX has been reviewed by the Western Institutional Review Board, and since only de-identified data were used, additional IRB approval and informed consent was not required. TriNetX offers access to continuously updated, de-identified aggregate EHR data, including demographics, diagnoses, procedures, medications, laboratory values, genomics, and cohort analysis tools. Detailed information regarding the TriNetX database and software has been previously published [14,15].

Cohorts

Patients aged 65 and older undergoing TSA or RSA on or prior to September 23, 2024, with a previous diagnosis of shoulder OA were first queried. All patients with diagnoses of rotator cuff pathologies prior to their procedure were excluded using the following codes: M75.1A, M75.5A, and S46.0A. The diagnosis of OA in both cohorts was identified using the following International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) codes: M19.019, M19.012, M19.011, M19.21, M12.211, M19.212, and M19.219. RSA patients were identified with the ICD-10 Procedure Coding System (ICD-10-PCS) codes 0RRK00Z and 0RRJ00Z, whereas TSA patients were identified with the ICD-10-PCS codes 0RRJ0JZ, 0RRJ07Z, 0RRK0JZ, 0RRK07Z, 0RRJ0KZ, and 0RRK0KZ. Each cohort excluded patients identified by the ICD-10-PCS codes of the other cohort.

Analysis and Statistics

Demographic and patient characteristic data were collected and compared using TriNetX’s cohort comparison tools. Propensity score matching was conducted using the platform, which applies logistic regression to user-defined covariates to generate propensity scores for individual subjects. A 1:1 matching approach was then performed using a greedy nearest neighbor algorithm with a caliper width of 0.1 pooled standard deviations. To mitigate bias associated with the nearest neighbor algorithm, TriNetX randomizes the row order during the matching process. The matched characteristics and comorbidities included average age at index, sex, race, body mass index (BMI), and the incidence of hypertension, diabetes, nicotine dependence, heart failure, chronic obstructive pulmonary disease (COPD), end-stage renal disease (ESRD), and ascites. Standardized mean differences (SMDs) were used to ascertain the distribution balance among our baseline variables. All variables had SMD values of less than 0.1 and were considered well-matched.

Following matching, infectious and orthopedic complication rates were tracked in each cohort from the first day after surgery (index event) for 90 days. Pertinent codes used to query these outcomes are found in Supplementary Table 1. An additional category named “Any Orthopedic Complication” was created to ascertain an overview of musculoskeletal adverse events including dislocation, periprosthetic fracture, scapula fracture, implant loosening, stiffness, rotator cuff injury, and hematoma. Risk differences were utilized to compare outcomes across groups, and significant differences were calculated with t-tests using the TriNetX platform. Significance was set at P<0.05.

Additionally, multivariable risk factor analysis was conducted independently for both the RSA and TSA cohorts using TriNetX’s logistic regression tool. This analysis examined the risk for orthopedic and infectious complications concerning patient comorbidities. Infections as an outcome of logistic regression were defined by the presence of any of the following: musculoskeletal infection, deep and superficial surgical site infection, wound dehiscence, unspecified infection, or sepsis (Supplementary Table 1). P-values less than 0.05 were considered significant.

RESULTS

This study included 5,058 patients who underwent RSA and 6,064 patients who underwent TSA. After 1:1 propensity matching, 4,117 patients were extracted from the cohorts (Fig. 1). The average age was similar between the RSA (72.67±5.00 years) and TSA (72.6±4.77 years) groups (P=0.291). Sex distribution showed no significant differences, with 55.55% females in the RSA group and 55.14% in the TSA group (P=0.706), and racial and ethnicity distributions remained comparable, with no significant differences. Comorbidities such as hypertension, diabetes mellitus, nicotine dependence, heart failure, COPD, ESRD, and ascites were also similar between the matched RSA and TSA cohorts. Statistically significant differences in BMI (30.7±6.60 in RSA vs. 30.2±6.11 in TSA) persisted despite matching (Table 1).

Fig. 1.

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) flowchart for patient selection. RSA: reverse shoulder arthroplasty, TSA: total shoulder arthroplasty.

Matched and unmatched demographic and comorbidity characteristics for included patients

In the matched cohorts, significant differences were observed in postoperative complications between RSA and TSA patients (Table 2). The RSA group had a significantly higher musculoskeletal infection rate than the TSA group (1.39% vs. 0.39%, P<0.001). Additionally, “any orthopedic complication” was more common in the RSA group, occurring in 7.65% of patients compared to 6.63% in the TSA group, though this difference did not reach statistical significance (P=0.072).

Matched incidence of postoperative complications for patients age ≥65 after RSA or TSA for osteoarthritis

Specific orthopedic complications were significantly more frequent in the RSA group. Dislocations were notably higher among RSA patients, occurring in 0.87% of cases compared to 0.27% in the TSA group (P<0.001). Periprosthetic fractures were also significantly more common following RSA (0.85% vs. 0.24%, P<0.001). Stiffness occurred at a higher rate in TSA patients (5.51%) compared to RSA patients (4.23%), showing a statistically significant difference (P=0.006). Rotator cuff injuries were more prevalent in the RSA group (1.43%) compared to the TSA group (0.41%) with a risk difference of 1.02% (P<0.001).

Beyond orthopedic complications, the RSA group demonstrated significantly higher rates of renal complications (4.20% vs. 2.84%, P<0.001), cardiovascular complications (6.32% vs. 5.27%, P=0.043), urinary tract infections (UTIs; 1.84% vs. 1.29%, P=0.041), and deep vein thrombosis (0.56% vs. 0.95%, P=0.041). Other vascular complications were significantly less common in RSA compared to TSA (0.56% vs. 1.00%, P=0.024). No significant differences were observed between groups in terms of surgical site infection, gastrointestinal complications, and hematological complications.

Table 3 presents multivariate risk factor analysis for orthopedic complications based on comorbidities of patients undergoing RSA or TSA for OA. In the RSA group, significant risk factors for orthopedic complications included a personal history of nicotine dependence (odds ratio [OR], 1.592; 95% CI, 1.204–2.106; P=0.001) and hypertension (OR, 1.545; 95% CI, 1.196–1.997; P=0.001). Age at index was identified as a protective factor, with an OR of 0.962 (95% CI, 0.942–0.983; P<0.001), suggesting that increasing age was associated with a reduced likelihood of orthopedic complications following RSA.

Multivariate risk factor analysis for orthopedic complications as related to comorbidities of patients undergoing RSA or TSA for osteoarthritis

In the TSA group, significant risk factors for orthopedic complications included male sex (OR, 0.702; 95% CI, 0.550–0.906; P=0.005), COPD (OR, 1.650; 95% CI, 1.099–2.478; P=0.016), overweight/obesity (OR, 1.776; 95% CI, 1.318–2.393; P<0.001), and hypertension (OR, 1.769; 95% CI, 1.348–2.323; P<0.001). Age at index was also a significant protective factor in TSA, with an OR of 0.962 (95% CI, 0.937–0.988; P=0.004), consistent with the trend observed in RSA patients.

Table 4 presents the multivariate risk factor analysis for infection based on comorbidities of patients undergoing RSA or TSA for OA. In the RSA group, significant risk factors for infection included heart failure (OR, 2.396; 95% CI, 1.504–3.818; P<0.001), male sex (OR, 1.698; 95% CI, 1.175–2.452; P=0.005), and diabetes mellitus (OR, 1.525; 95% CI, 1.022–2.277; P=0.039). Age at index was protective against infection, with an OR of 0.939 (95% CI, 0.905–0.974; P=0.001), indicating that increasing age was associated with a decreased likelihood of infection following RSA. In the TSA group, diabetes mellitus was a significant risk factor for infection (OR, 2.453; 95% CI, 1.362–4.416; P=0.003). No other comorbidities were significantly associated with infection in the TSA cohort.

Multivariate risk factor analysis for infections as related to comorbidities of patients undergoing RSA or TSA for osteoarthritis

DISCUSSION

This study compared 90-day orthopedic and infectious complications following TSA vs. RSA for OA, identifying associated risk factors. While prior research examined shoulder arthroplasty complications, few studies focus specifically on TSA vs. RSA in OA and sought to identify relevant risk factors for adverse events. To the best of our knowledge, this is the largest database study on this topic conducted to inform surgical decision-making by identifying high-risk patient populations.

Postoperative Complications

Patients treated with RSA experienced a significantly higher number of musculoskeletal infections compared to TSA. In contrast to Ross et al. [16], who reported a 0.5% rate of prosthetic joint infections 90 days following RSA, our rate of musculoskeletal infections was two-fold that rate at 1.39%. Variation in diagnosis codes across studies when defining infection may yield differences in results, as our musculoskeletal infection category consisted of multiple diagnosis codes. Nonetheless, our findings are compatible with prior literature, which generally reported higher rates of infectious complications following RSA compared to TSA [16,17]. Previously suggested mechanisms to explain this disparity ranged from variation in implant type to surgical techniques [18]. Overall, the rate of musculoskeletal infections following shoulder arthroplasty in our study fell within the published range of 1% to 10% of prosthetic joint infections [19].

Although RSA may be performed in patients with existing rotator cuff deficiencies, patients with a previous diagnosis of rotator cuff arthropathy were excluded from this study to identify new postoperative deficiencies. A significantly lower number of postoperative rotator cuff injuries were found in patients treated with TSA than RSA. The higher rate of rotator cuff injuries following RSA in our study may reflect intraoperative variation between RSA and TSA, with undiagnosed rotator cuff deficiencies more frequently discovered during RSA. This warrants further investigation [20].

Postoperative dislocation was observed at a higher rate following RSA, at 0.87% compared to0.27% in TSA in the present study. Rates of dislocation in RSA vary widely from 2.4% to 31% in the existing literature, whereas our study found a dislocation rate under 1% [21]. We hypothesize that an outcome window of 90 days may have been insufficient to capture the true rate, accounting for this difference. Instability in RSA may vary from TSA due to differences related to implant type, lack of soft tissue tension, impingement, and a deltopectoral approach leading to eventual dislocation [19,22]. Furthermore, RSA places greater reliance on the deltoid muscle, and inadequate tension may create instability or future dislocations. Finally, greater BMI, as seen with the RSA cohort, as well as a history of prior surgery (not accounted for in this study) constitute potential nonsurgical risk factors for dislocation [18].

Stiffness was observed at greater rates in our TSA cohort (5.51%) compared to RSA (4.23%). Although few studies have examined this relationship in the context of OA, the higher rate of early stiffness following TSA compared to RSA is logical considering their respective postoperative rehabilitation protocols. TSA involves relatively stricter postoperative immobilization, whereas early range of motion is more strongly encouraged in RSA [23,24]. Although early stiffness during the 90-day postoperative period is not necessarily indicative of a surgical complication, it can persist beyond 1-year postoperative in up to 25% of patients following RSA, limiting shoulder function, decreasing patient satisfaction, and necessitating reoperation [17,25]. Still, despite increased stiffness, TSA generally yields better postoperative range of motion compared to RSA [26,27]. The contradictory findings in TSA may stem from yet-undetermined biomechanical mechanisms. For instance, one study linked early stiffness to improved tendon healing after arthroscopic rotator cuff repair [28]. While rotator cuff pathology was excluded from our study, a similar mechanism may underlie our results. Further research is needed to determine whether such biomechanical factors apply to shoulder arthroplasty for OA.

After matching to account for comorbidity and demographic differences, patients experienced a periprosthetic fracture rate of 0.85% following treatment with RSA compared to 0.61% in patients treated with TSA. Published literature has demonstrated similarly increased rates of periprosthetic fractures in patients undergoing RSA compared to TSA [16-18]. In RSA, acromial and scapular spine fractures as well as humeral fractures are observed, with rates documented to be between 4.5% and 3.5% respectively [29]. Intraoperative glenoid and humeral fractures are reported to increase the risk of subsequent periprosthetic fracture and may be more likely depending on existing patient characteristics such as glenoid arthritis or osteopenia [17,18]. Furthermore, screw placement, implant design, and deltoid lengthening are risk factors implicated in periprosthetic fracture following RSA.

When comparing nonorthopedic complications, we found greater rates of renal complications as well as deep vein thrombosis in patients undergoing RSA, which is consistent with the existing literature [16,30]. Prior research established older age (>70 years), higher comorbidity, and history of cardiac or thromboembolic events as risk factors for 90-day cardiac and thromboembolic complications following primary TSA [31]. Higher rates of UTIs were also observed among the RSA group. Although previous reports comparing UTI in the setting of RSA versus TSA are sparse, existing research on total joint arthroplasty has identified increasing age, female sex, steroid use, operative time greater than 130 minutes, and preoperative creatinine as risk factors for UTI [32].Taken together, the literature regarding the risk for medical complications in total joint arthroplasty overwhelmingly attributes differences to age, comorbidity, and sex. Further research is required to identify risk factors for these medical complications based on additional comorbidities not explored in the present study as well as intraoperative factors, which are not available on TriNetX.

Risk Factors for Orthopedic Complications

A secondary aim of this study was to determine risk factors for orthopedic complications following shoulder arthroplasty, with a greater number of significant risk factors identified in the TSA group (Table 3). Hypertension was a significant risk factor for orthopedic complications in both the RSA and TSA groups. Prior research found hypertension to be a risk factor for fracture as well as extended hospital stay, which may contribute to postoperative stiffness [33,34]. Increasing age was associated with a lower risk of orthopedic complications in both the RSA and TSA groups, suggesting that older patients may experience fewer postoperative complications despite often having greater comorbidity burdens. This protective effect may stem from lower functional demands, reduced mechanical stress on implants, and more conservative rehabilitation protocols in older patients, highlighting the need for further investigation.

Risk factors that were significant exclusively in the RSA group included a personal history of nicotine dependence. Prior research identified active tobacco use as a risk factor for numerous complications in the 90-day window following TSA including fractures, dislocation, and other forms of instability; the underlying mechanisms are multifaceted and have been attributed to the deleterious effects of nicotine on bone density, peripheral blood flow, and gene expression in healing tendons [35].

In TSA, risk factors included male sex, COPD, and obesity. Male sex was associated with a lower risk of orthopedic complications, but other literature attributed this to male TSA patients often being younger and more active, which could influence long-term mechanical failure rates. This lack of consensus regarding sex-specific TSA outcomes warrants further study [36-40]. COPD was a significant risk factor, consistent with literature linking it to periprosthetic fracture, implant failure, instability, and stiffness, likely due to chronic inflammation and physical inactivity [41]. Obesity was the strongest TSA-specific risk factor. Prior studies have demonstrated that obesity contributes to higher joint loading, altered biomechanics, increased intraoperative complexity, and, consequently, greater risk of implant loosening, stiffness, periprosthetic fractures [42-45].

Risk Factors for Infectious Complications

This study also analyzed risk factors for infectious complications within the 90-day postoperative period following RSA and TSA performed for OA (Table 4). Diabetes mellitus was a significant risk factor for infections in both the RSA and TSA groups, consistent with previous literature in which diabetes mellitus is well-documented as a risk factor for postoperative infection due to its detrimental effects on immune response and wound healing [46].

In the RSA group, male sex and heart failure were identified as significant risk factors for infectious complications. Heart failure, which is associated with systemic inflammation and poor circulation, also significantly raises the risk of infection following RSA [47]. The higher risk for infection in male RSA patients is well-documented and likely multifactorial, involving a greater comorbidity burden, weaker immune response compared to females, and perhaps social factors such as lower adherence to postoperative care and higher rates of smoking and alcohol use [36,48,49]. There were no significant risk factors for infection exclusive to the TSA group.

Limitations

This study is not without its limitations. First, while TriNetX offers the advantage of analyzing a large sample size, this same feature limits data analysis due to its reliance on medical billing codes (e.g., ICD-10, Current Procedural Terminology) to establish cohorts and compare outcomes. Although the selection of codes was informed by a thorough literature review, the coding process is inherently subjective, and as such any given combination of codes may conceivably fail to capture some members of the target cohort (in this case, readmitted TSA or RSA recipients) due to discrepancies in coding across institutions or even inaccuracies in coding. Similarly, not all adverse events identified in this analysis necessarily represent unintended complications of the procedure itself. For example, pre-existing rotator cuff pathology is frequently managed with RSA, and patients who had such diagnoses prior to surgery may continue to experience symptoms in the short term. As a result, follow-up encounters coded for rotator cuff-related issues may be captured as complications in this dataset, even though they may reflect the natural progression of a pre-existing condition rather than a new postoperative complication. Several differences in baseline comorbidities persisted despite propensity matching, including white ethnicity, nicotine dependence, COPD, and ascites; thus, some differences such as the postoperative occurrence of respiratory complications could be attributed in part to baseline group differences in COPD rather than the procedures alone. Additionally, the present study investigated complications confined to the 90-day postoperative window, which may not be sufficient to fully capture procedure-related adverse events that occur later in the postoperative period. One final limitation of the TriNetX database is the possibility that one or more HCO is unresponsive when querying the database, potentially yielding inconsistent results when attempting to analyze outcomes for the same cohort across different time periods; this limitation was mitigated in this our study by replicating the present results multiple times to ensure any significant findings were consistently demonstrated across numerous queries. Furthermore, the retrospective nature of this study may also hinder the ability to establish causality. Variation in surgical techniques and patient management strategies, which are not accounted for in this study, may influence outcomes and should be considered when interpreting the results.

Future research should examine similar orthopedic and infectious outcomes over a longer postoperative course, beyond the 90-day postoperative window. Additional research encompassing a broader array of complications in various organ systems and/or indications for revision surgery, would likewise contribute to a more complete understanding of the different outcomes observed following TSA and RSA.

CONCLUSIONS

RSA carries a greater risk for orthopedic complications than TSA in the 90-day postoperative period when considering elderly patients undergoing surgery for OA. Significant risk factors for both orthopedic complications and infection included diabetes, hypertension, depression, liver disease, and cardiac arrhythmia. These differences likely result from differences in patient selection, intraoperative factors, and postoperative rehabilitation protocols between the two procedures. The present findings may inform surgical decision-making when assessing a patient’s candidacy for an elective RSA or TSA for OA and furthermore may help to improve surgical outcomes by encouraging surgeons and patients to address modifiable comorbidities preoperatively.

Notes

Author contributions

Conceptualization: SRV, BAL. Data curation: SRV, BAL, AS. Formal analysis: SRV, JS. Investigation: BAL, AS. Methodology: SRV, AS. Project administration: SRV. Resources: MS, JS. Supervision: MS, JS, JV. Validation: MS, JS. Visualization: BAL, JV. Writing – original draft: SRV, BAL, AS. Writing – review & editing: SRV, BAL, AS, MS, JS, JV. All authors read and agreed to the published version of the manuscript.

Conflict of interest

None.

Funding

None.

Data availability

Contact the corresponding author for data availability.

Acknowledgments

None.

SUPPLEMENTARY MATERIALS

Supplementary materials can be found via https://doi.org/10.5397/cise.2024.00906.

Supplementary Table 1.

ICD-10 codes used to identify outcomes and complications

cise-2024-00906-Supplementary-Table-1.pdf

References

1. Westermann RW, Pugely AJ, Martin CT, Gao Y, Wolf BR, Hettrich CM. Reverse shoulder arthroplasty in the United States: a comparison of national volume, patient demographics, complications, and surgical indications. Iowa Orthop J 2015;35:1–7. 26361437.
2. Ansok CB, Muh SJ. Optimal management of glenohumeral osteoarthritis. Orthop Res Rev 2018;10:9–18. 10.2147/orr.s134732. 30774456.
3. Kobayashi T, Takagishi K, Shitara H, et al. Prevalence of and risk factors for shoulder osteoarthritis in Japanese middle-aged and elderly populations. J Shoulder Elbow Surg 2014;23:613–9. 10.1016/j.jse.2013.11.031. 24561177.
4. Burden EG, Batten TJ, Smith CD, Evans JP. Reverse total shoulder arthroplasty. Bone Joint J 2021;103:813–21. 10.1302/0301-620x.103b.bjj-2020-2101. 33616421.
5. Bufquin T, Hersan A, Hubert L, Massin P. Reverse shoulder arthroplasty for the treatment of three- and four-part fractures of the proximal humerus in the elderly: a prospective review of 43 cases with a short-term follow-up. J Bone Joint Surg Br 2007;89:516–20. 10.1302/0301-620X.89B4.18435. 17463122.
6. Ling K, Tsouris N, Nazemi A, Komatsu DE, Wang ED. Identifying risk factors for 30-day readmission after outpatient total shoulder arthroplasty to aid in patient selection. JSES Int 2023;7:2425–32. 10.1016/j.jseint.2023.06.015. 37969527.
7. Crane C, Wagner C, Wong S, et al. Glenohumeral osteoarthritis: a biological advantage or a missed diagnosis. J Clin Med 2024;13:2341. 10.3390/jcm13082341. 38673614.
8. Jo YH, Kim DH, Lee BG. When should reverse total shoulder arthroplasty be considered in glenohumeral joint arthritis. Clin Shoulder Elb 2021;24:272–8. 10.5397/cise.2021.00633. 34875733.
9. Loeser RF. The role of aging in the development of osteoarthritis. Trans Am Clin Climatol Assoc 2017;128:44–54. 28790486.
10. Gerber C, Pennington SD, Nyffeler RW. Reverse total shoulder arthroplasty. J Am Acad Orthop Surg 2009;17:284–95. 10.5435/00124635-200905000-00003. 19411640.
11. Villacis D, Sivasundaram L, Pannell WC, Heckmann N, Omid R, Hatch GF 3rd. Complication rate and implant survival for reverse shoulder arthroplasty versus total shoulder arthroplasty: results during the initial 2 years. J Shoulder Elbow Surg 2016;25:927–35. 10.1016/j.jse.2015.10.012. 26796602.
12. Daher M, Boufadel P, Fares MY, et al. Reverse versus anatomic total shoulder arthroplasty for glenohumeral osteoarthritis with intact cuff: a meta-analysis of clinical outcomes. J Shoulder Elbow Surg 2025;34:190–202. 10.1016/j.jse.2024.06.026. 39142432.
13. Glen LZ, Cheong CK, Nistala KR, Sean PK, Pei LT, Ruben M. Outcomes of reverse total shoulder arthroplasties performed for proximal humeral fractures versus elective etiologies. Indian J Orthop 2022;56:1066–72. 10.1007/s43465-022-00625-4. 35669022.
14. Topaloglu U, Palchuk MB. Using a federated network of real-world data to optimize clinical trials operations. JCO Clin Cancer Inform 2018;2:1–10. 10.1200/cci.17.00067.
15. Stapff M. Use of electronic health data in clinical development [Internet]. Executives for Health Innovation; 2018. [cited 2025 Feb 4]. Available from: https://www.ehidc.org/resources/use-electronic-health-data-clinical-development.
16. Ross BJ, Wu VJ, McCluskey LC, O’Brien MJ, Sherman WF, Savoie FH. Postoperative complication rates following total shoulder arthroplasty (TSA) vs. reverse shoulder arthroplasty (RSA): a nationwide analysis. Semin Arthroplasty 2020;30:83–8. 10.1053/j.sart.2020.05.006.
17. Wickman JR, Goltz DE, Levin JM, Lassiter T, Anakwenze OA, Klifto CS. Early aseptic reoperation after shoulder arthroplasty increases risk of subsequent prosthetic joint infection. JSES Int 2021;5:1067–71. 10.1016/j.jseint.2021.06.002. 34766086.
18. Barco R, Savvidou OD, Sperling JW, Sanchez-Sotelo J, Cofield RH. Complications in reverse shoulder arthroplasty. EFORT Open Rev 2017;1:72–80. 10.1302/2058-5241.1.160003. 28461931.
19. Zhou HS, Chung JS, Yi PH, Li X, Price MD. Management of complications after reverse shoulder arthroplasty. Curr Rev Musculoskelet Med 2015;8:92–7. 10.1007/s12178-014-9252-9. 25576072.
20. Christensen GV, Bozoghlian MF, Hlas AC, Rund JM, Galvin JW, Patterson BM. Predictive factors of intraoperative conversion to reverse total shoulder arthroplasty in patients with primary glenohumeral arthritis. JSES Int 2024;Oct. 16. [Epub]. https://doi.org/10.1016/j.jseint.2024.09.026. 10.1016/j.jseint.2024.09.026.
21. Chalmers BP, Wagner ER, Sperling JW, Cofield RH, Sanchez-Sotelo J. Treatment and outcomes of reverse shoulder arthroplasty dislocations. J Shoulder Elb Arthroplast 2017;1:2471549217695260. 10.1177/2471549217695260.
22. Kohan EM, Chalmers PN, Salazar D, Keener JD, Yamaguchi K, Chamberlain AM. Dislocation following reverse total shoulder arthroplasty. J Shoulder Elb Surg 2017;26:1238–45. 10.1016/j.jse.2016.12.073.
23. Mehta N, Acuna AJ, McCormick JR, et al. Publicly available anatomic total shoulder arthroplasty rehabilitation protocols show high variability and frequent divergence from the 2020 ASSET recommendations. Int J Sports Phys Ther 2024;19:856–67. 10.26603/001c.118926. 38966826.
24. Hochberger F, Wild MF, Heinz T, Rudert M, List K. Comparative study on postoperative immobilization in reverse total shoulder arthroplasty: 4 weeks vs. 6 weeks of immobilization yields similar clinical and functional outcomes. J Clin Med 2024;13:6363. 10.3390/jcm13216363. 39518502.
25. Ghoraishian M, Hill BW, Nicholson T, Ramsey ML, Williams GR Jr, Namdari S. Postoperative stiffness after reverse total shoulder arthroplasty. Shoulder Elbow 2022;14:150–6. 10.1177/1758573220967312. 35265180.
26. Kirsch JM, Puzzitiello RN, Swanson D, et al. Outcomes after anatomic and reverse shoulder arthroplasty for the treatment of glenohumeral osteoarthritis: a propensity score-matched analysis. J Bone Joint Surg Am 2022;104:1362–9.
27. Su F, Nuthalapati P, Feeley BT, Lansdown DA. Outcomes of anatomic and reverse total shoulder arthroplasty in patients over the age of 70: a systematic review. JSES Rev Rep Tech 2023;3:181–8. 10.1016/j.xrrt.2023.02.003. 37588441.
28. Takahashi R, Kawakami K, Harada Y, Kouzaki K, Kajita Y. Early postoperative stiffness after arthroscopic rotator cuff repair correlates with improved tendon healing. Arthroscopy 2024;40:2186–94. 10.1016/j.arthro.2024.01.038. 38325498.
29. Brusalis CM, Taylor SA. Periprosthetic fractures in reverse total shoulder arthroplasty: current concepts and advances in management. Curr Rev Musculoskelet Med 2020;13:509–19. 10.1007/s12178-020-09654-8. 32506260.
30. Ponce BA, Oladeji LO, Rogers ME, Menendez ME. Comparative analysis of anatomic and reverse total shoulder arthroplasty: in-hospital outcomes and costs. J Shoulder Elbow Surg 2015;24:460–7. 10.1016/j.jse.2014.08.016. 25441557.
31. Singh JA, Sperling JW, Cofield RH. Cardiopulmonary complications after primary shoulder arthroplasty: a cohort study. Semin Arthritis Rheum 2012;41:689–97. 10.1016/j.semarthrit.2011.09.003. 22055539.
32. Alvarez AP, Demzik AL, Alvi HM, Hardt KD, Manning DW. Risk factors for postoperative urinary tract infections in patients undergoing total joint arthroplasty. Adv Orthop 2016;2016:7268985. 10.1155/2016/7268985. 28018678.
33. Vestergaard P, Rejnmark L, Mosekilde L. Hypertension is a risk factor for fractures. Calcif Tissue Int 2009;84:103–11. 10.1007/s00223-008-9198-2. 19067019.
34. Gupta P, Quan T, Patel CJ, Gu A, Campbell JC. Extended length of stay and postoperative complications in octogenarians with hypertension following revision total knee arthroplasty. J Clin Orthop Trauma 2022;26:101787. 10.1016/j.jcot.2022.101787. 35145852.
35. Schwartz AM, Farley KX, Boden SH, et al. The use of tobacco is a modifiable risk factor for poor outcomes and readmissions after shoulder arthroplasty. Bone Joint J 2020;102:1549–54. 10.1302/0301-620x.102b11.bjj-2020-0599.r1. 33135438.
36. Ezuma CO, Kosber RL, Kovacevic D. Biological sex impacts perioperative complications after reverse shoulder arthroplasty for proximal humeral fracture. JSES Int 2021;5:371–6. 10.1016/j.jseint.2020.12.005. 34136842.
37. Gruskay JA, Fu M, Basques BA, et al. Factors affecting length of stay and complications after elective anterior cervical discectomy and fusion: a study of 2164 patients from The American College of Surgeons National Surgical Quality Improvement Project Database (ACS NSQIP). Clin Spine Surg 2016;29:E34–42. 10.1097/BSD.0000000000000080. 24525748.
38. Lehtimäki K, Rasmussen JV, Mokka J, et al. Risk and risk factors for revision after primary reverse shoulder arthroplasty for cuff tear arthropathy and osteoarthritis: a Nordic Arthroplasty Register Association study. J Shoulder Elbow Surg 2018;27:1596–601. 10.1016/j.jse.2018.02.060. 29779980.
39. Manoharan SR, Baker DK, Pasara SM, Ponce B, Deinlein D, Theiss SM. Thirty-day readmissions following adult spinal deformity surgery: an analysis of the National Surgical Quality Improvement Program (NSQIP) database. Spine J 2016;16:862–6. 10.1016/j.spinee.2016.03.014. 26975458.
40. Hung NJ, Wong SE. Gender influences on shoulder arthroplasty. Curr Rev Musculoskelet Med 2022;15:21–6. 10.1007/s12178-021-09737-0. 34982405.
41. Lee R, Lee D, Mamidi IS, Probasco WV, Heyer JH, Pandarinath R. Patients with chronic obstructive pulmonary disease are at higher risk for pneumonia, septic shock, and blood transfusions after total shoulder arthroplasty. Clin Orthop Relat Res 2019;477:416–23. 10.1097/corr.0000000000000531. 30664604.
42. Werner BC, Burrus MT, Browne JA, Brockmeier SF. Superobesity (body mass index >50 kg/m2) and complications after total shoulder arthroplasty: an incremental effect of increasing body mass index. J Shoulder Elbow Surg 2015;24:1868–75. 10.1016/j.jse.2015.05.046. 26190668.
43. Shengyuan T, Zihang X, Changbing W, Junhua W, Hong W. The influence of obesity on the complications and outcomes of shoulder arthroplasty: a systematic review and meta-analysis. Acta Orthop Traumatol Turc 2023;57:154–60. 10.5152/j.aott.2023.20300. 37670449.
44. Wall KC, Politzer CS, Chahla J, Garrigues GE. Obesity is associated with an increased prevalence of glenohumeral osteoarthritis and arthroplasty: a cohort study. Orthop Clin North Am 2020;51:259–64. 10.1016/j.ocl.2019.12.001. 32138863.
45. Linberg CJ, Sperling JW, Schleck CD, Cofield RH. Shoulder arthroplasty in morbidly obese patients. J Shoulder Elbow Surg 2009;18:903–6. 10.1016/j.jse.2009.02.006. 19464930.
46. Cancienne JM, Brockmeier SF, Werner BC. Association of perioperative glycemic control with deep postoperative infection after shoulder arthroplasty in patients with diabetes. J Am Acad Orthop Surg 2018;26:e238–45. 10.5435/jaaos-d-16-00784. 29688958.
47. Hasper D, Hummel M, Kleber FX, Reindl I, Volk HD. Systemic inflammation in patients with heart failure. Eur Heart J 1998;19:761–5. 10.1053/euhj.1997.0858. 9717010.
48. Nolen-Hoeksema S. Gender differences in risk factors and consequences for alcohol use and problems. Clin Psychol Rev 2004;24:981–1010. 10.1016/j.cpr.2004.08.003. 15533281.
49. Fernandez AC, Bohnert KM, Bicket MC, Weng W, Singh K, Englesbe M. Adverse surgical outcomes linked to co-occurring smoking and risky alcohol use among general surgery patients. Ann Surg 2023;278:201–7. 10.1097/sla.0000000000005735. 36268706.

Article information Continued

Fig. 1.

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) flowchart for patient selection. RSA: reverse shoulder arthroplasty, TSA: total shoulder arthroplasty.

Table 1.

Matched and unmatched demographic and comorbidity characteristics for included patients

Variable Unmatched
P-value Matched
P-value
RSA TSA RSA TSA
Cohort population 5,058 6,064 - 4,117 4,117 -
Average age at index (yr) 73.7±5.3 71.4±4.7 <0.001* 72.7±5.0 72.6±4.8 0.291
Female 3,039 (60.08) 2,917 (48.10) <0.001* 2,287 (55.55) 2,270 (55.14) 0.706
Male 1,921 (37.98) 3,028 (49.93) <0.001 1,743 (42.34) 1,743 (42.34) 0.688
Unknown sex 98 (1.94) 119 (1.96) 0.935 87 (2.11) 86 (2.09) 0.939
White 4,271 (84.44) 5,290 (87.24) <0.001* 3,551 (86.25) 3,556 (86.37) 0.873
African American 263 (5.20) 231 (3.81) <0.001* 176 (4.28) 117 (2.30) 0.957
Asian 47 (0.93) 90 (1.48) 0.008* 46 (1.12) 35 (0.85) 0.219
American Indian 13 (0.26) 10 (0.17) 0.287 10 (0.24) 10 (0.24) 1.000
Pacific islander 10 (0.20) 14 (0.23) 0.707 10 (0.24) 10 (0.24) 1.000
Other race 113 (2.23) 154 (1.90) 0.370 89 (2.16) 88 (2.14) 0.939
Unknown race 348 (6.88) 119 (1.96) <0.001* 247 (6.00) 253 (6.15) 0.782
Hispanic or Latino 134 (2.65) 89 (1.47) <0.001* 85 (2.06) 81 (1.97) 0.754
Not Hispanic or Latino 3,928 (77.66) 4,063 (67.00) <0.001* 3,121 (75.81) 3,172 (86.37) 0.186
Unknown ethnicity 996 (19.69) 1,912 (31.53) <0.001* 911 (22.13) 864 (20.97) 0.208
Average BMI (kg/m2) 30.62±6.59 30.25±6.02 0.009* 30.7±6.6 30.2±6.11 <0.001*
Hypertension 2,741 (54.19) 2,832 (46.70) <0.001* 2,105 (51.13) 2,128 (51.69) 0.612
Diabetes mellitus 968 (19.14) 885 (14.59) <0.001* 707 (17.17) 716 (17.39) 0.793
History of nicotine dependence 801 (15.84) 634 (10.46) <0.001* 551 (13.38) 541 (13.41) 0.745
Heart failure 441 (8.72) 265 (4.37) <0.001* 244 (5.93) 241 (5.85) 0.801
COPD 451 (8.92) 351 (5.79) <0.001* 306 (7.43) 300 (7.29) 0.800
ESRD 24 (0.47) 21 (0.35) 0.289 15 (0.36) 17 (0.41) 0.723
Ascites 37 (0.73) 33 (0.36) 0.008* 18 (0.44) 20 (0.47) 0.745

Values are presented as mean±standard deviation or number (%).

RSA: reverse shoulder arthroplasty, TSA: total shoulder arthroplasty, BMI: body mass index, COPD: chronic obstructive pulmonary disease, ESRD: end-stage renal disease.

*

P-values <0.05.

Table 2.

Matched incidence of postoperative complications for patients age ≥65 after RSA or TSA for osteoarthritis

Variable RSA TSA Risk difference (%) P-value
All-cause mortality 11 (0.27) ≤10 (0.24) 0.024 0.827
Wound disruptions 16 (0.39) ≤10a) (0.24) 0.15 0.239
 Organ space SSI ≤10a) (0.24) 0 0.24 0.001*
 Superficial incisional SSI ≤10a) (0.24) ≤10a) (0.24) 0 1.000
 Deep incisional SSI ≤10a) (0.24) ≤10a) (0.24) 0 1.000
 Wound dehiscence ≤10a) (0.24) ≤10a) (0.24) 0 1.000
Musculoskeletal infections 57 (1.39) 16 (0.39) 0.10 <0.001*
Sepsis and unspecified infections 29 (0.70) 25 (0.61) 0.09 0.585
Any orthopedic complication 315 (7.65) 273 (6.63) 1.01 0.072
 Dislocation 36 (0.87) 11 (0.27) 0.61 <0.001*
 Periprosthetic fracture 35 (0.85) ≤10a) (0.24) 0.61 <0.001*
 Scapula fracture 12 (0.29) ≤10a) (0.24) 0.05 0.669
 Implant loosening/failure 20 (0.49) ≤10a) (0.24) 0.24 0.067
 Stiffness 174 (4.23) 227 (5.51) –1.29 0.006*
 Rotator cuff injury 59 (1.43) 17 (0.41) 1.02 <0.001*
 Hematoma 12 (0.29) ≤10a) (0.05) 0.12 0.669
Renal complications 173 (4.20) 117 (2.84) 1.36 <0.001*
Cardiovascular complications 260 (6.32) 217 (5.27) 1.04 0.043*
Other vascular complications 23 (0.56) 41 (1.00) –0.44 0.024*
 DVT 23 (0.56) 39 (0.95) –0.39 0.041*
Respiratory complications 102 (2.48) 79 (1.92) 0.56 0.084
 PE 23 (0.56) 28 (0.68) –0.12 0.483
UTI 76 (1.84) 53 (1.29) 0.56 0.041*
GI complications 121 (2.94) 119 (2.89) 0.05 0.896
Hematological complications 203 (4.93) 172 (4.18) 0.75 0.101

Values are presented as number (%).

RSA: reverse shoulder arthroplasty, TSA: total shoulder arthroplasty, SSI: surgical site infection, DVT: deep vein thrombosis, PE: pulmonary embolism, UTI: urinary tract infections, GI: gastrointestinal.

a)

Less than 10 instances of the complication were found.

*

P-value <0.05;

Table 3.

Multivariate risk factor analysis for orthopedic complications as related to comorbidities of patients undergoing RSA or TSA for osteoarthritis

Covariate RSA
TSA
OR 2.5% CI 97.5% CI P-value OR 2.5% CI 97.5% CI P-value
Age at index 0.962 0.942 0.983 <0.001* 0.962 0.937 0.988 0.004*
Male sex 0.945 0.753 1.187 0.629 0.702 0.550 0.896 0.005
Diabetes mellitus 1.084 0.819 1.434 0.574 0.732 0.517 1.035 0.077
Personal history of nicotine dependence 1.592 1.204 2.106 0.001* 1.065 0.743 1.527 0.730
COPD 1.084 0.819 1.434 0.520 1.650 1.099 2.478 0.016*
Heart failure 1.418 0.995 2.021 0.053 1.140 0.687 1.892 0.611
Overweight/obesity 0.942 0.714 1.243 0.672 1.776 1.318 2.393 <0.001*
Hypertension 1.545 1.196 1.997 0.001* 1.769 1.348 2.323 <0.001*

RSA: reverse shoulder arthroplasty, TSA: total shoulder arthroplasty, OR: odds ratio, COPD: chronic obstructive pulmonary disease.

*

P-value <0.05.

Table 4.

Multivariate risk factor analysis for infections as related to comorbidities of patients undergoing RSA or TSA for osteoarthritis

Covariate RSA
TSA
OR 2.5% CI 97.5% CI P-value OR 2.5% CI 97.5% CI P-value
Age at index 0.939 0.905 0.974 0.001* 0.939 0.881 1.000 0.051
Male sex 1.698 1.175 2.452 0.005 1.145 0.661 1.980 0.629
Diabetes mellitus 1.525 1.022 2.277 0.039* 2.453 1.362 4.416 0.003*
Personal history of nicotine dependence 1.354 0.902 2.032 0.143 1.419 0.766 2.627 0.266
COPD 1.228 0.744 2.027 0.422 1.513 0.655 3.497 0.333
Heart failure 2.396 1.504 3.818 <0.001* 0.723 0.209 2.497 0.608
Overweight/obesity 1.156 0.775 1.725 0.476 0.809 0.426 0.536 0.517
Hypertension 1.605 0.988 2.607 0.560 1.924 0.936 3.956 0.075

RSA: reverse shoulder arthroplasty, TSA: total shoulder arthroplasty, OR: odds ratio, COPD: chronic obstructive pulmonary disease.

*

P-value <0.05.